Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Response Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning Nov 14, 2022
Oral, Hormone-Free Med Reduces Hot Flashes in Breast Cancer Patients Q-122 was effective, well-tolerated in those on oral adjuvant endocrine therapy Nov 11, 2022
Terry Bradshaw's Merkel Cell Carcinoma After beating bladder cancer, the Hall of Fame quarterback was diagnosed with a rare skin tumor Nov 10, 2022
Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancer Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
Immune Stimulator May Enhance Targeted Therapy's Activity in Metastatic RCC Numerical advantage in median survival, response rate, durability with dendritic-cell agent Nov 09, 2022
Immunotherapy Doublet Shows Promise for Nonsurgical Control of Small Kidney Cancers Nivolumab/ipilimumab achieves 1-year PFS of 100% in unresectable T1N0M0 tumors Nov 07, 2022
Lucky to Be Scoped My screening colonoscopy went really well, but how many people don't get the chance to have one? Nov 07, 2022
Probiotic May Rev Up Response to Immunotherapy in Advanced Kidney Cancer Dramatic slowing of disease progression, prolonged responses with microbiome modulator Nov 06, 2022
Psilocybin for Depression; What's the Best Direct Oral Anticoagulant? Also in TTHealthWatch: hormone therapy to prevent chronic disease Nov 05, 2022 podcast
Boys Who Lose Excess Pounds by College May Still See Elevated Cancer Risk Long-term Swedish study suggests early obesity "programming" in males has lasting impact Nov 04, 2022
Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
Lenalidomide-Induced Second Cancer Risk Limited to Multiple Myeloma No increased risk to patients with other hematologic malignancies, meta-analysis shows Nov 02, 2022
Study: U.S. Chemo Regimen for Ewing Sarcoma Should Be International Standard Europe and other countries have already followed suit Nov 01, 2022
My Risk Revealed: A Confirmed BRCA2 Mutation My dad's cancer diagnosis offered me invaluable information Oct 30, 2022
Could a Plant-Based Diet Benefit Men's Health Below the Belt? Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more Oct 30, 2022
Good, and Safe, Results Tied to Oral Testosterone in Men With Deficiency Meta-analysis should spur more research on newer formulations, researcher says Oct 30, 2022
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
Ablative MR-Guided RT Shows Promise in Pancreatic Cancer SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data Oct 27, 2022
Study Suggests Potential to Skip Surgery for Selected Breast Cancer Patients No recurrences in 2 years after pathologic complete response in TNBC, HER2-positive tumors Oct 26, 2022
Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival Fewer skeletal events, less pain unexpectedly followed by longer life Oct 26, 2022
FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamab Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer Will USPSTF's 2018 guidelines reverse this trend? Oct 25, 2022
New Standard-of-Care Therapy for Advanced Liver Cancer Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
Nerve-Freezing Technique Staves Off Post-Mastectomy Pain Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
Rapid Radiotherapy Technique Shows Promise in First Human Trial FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
FDA Approves New CTLA-4 Inhibitor for Cancer Treatment Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
Is Your Oven Leaking Cancer-Causing Chemicals Into Your Kitchen? Study finds that natural gas leaks result in elevated benzene levels, even when stove not in use Oct 20, 2022
Should We Still Be Concerned About Cell Phones and Brain Cancer? Experts weigh in on why the topic has seemed to lose steam in recent years Oct 20, 2022
Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancer "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggests Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer Risk is low but appears to have modifiable components Oct 13, 2022
U.S. Experts Weigh In on Colonoscopy Status in Wake of European Trial Concerns abound after study suggests colonoscopy may be less effective than expected Oct 12, 2022
Caregiving at the End Co-host Tyler Johnson talks with the husband of previous guest, Ellen Dunphy, who died in July Oct 11, 2022 podcast
Lung Cancer Screening Programs Hit the Mark on Eligibility Criteria However, adherence to follow-up screening is "suboptimal" Oct 10, 2022
More Evidence Backing Anti-CDK4/6-Based Therapy in Recurrent Endometrial Cancer Abemaciclib plus letrozole led to 30% objective response rate, 55.6% PFS rate at 6 months Oct 10, 2022
If You Invite 455 People to Colonoscopy, You'll Stop One Case of Cancer Risk of colorectal cancer reduced with screening in randomized trial, but less than expected Oct 09, 2022
